Foliculustan

Foliculustan is a synthetic hormone that is chemically similar to the human hormone follicle-stimulating hormone (FSH). It is used in medical settings to stimulate the production of eggs in women undergoing fertility treatments, such as in vitro fertilization (IVF) and ovarian stimulation. Foliculustan is administered through injections and works by mimicking the natural action of FSH, which is essential for the development of follicles in the ovaries.

The primary use of foliculustan is to induce multiple follicles to mature simultaneously, thereby increasing the number of eggs available for retrieval. This process is crucial for improving the chances of successful fertilization and pregnancy in women with certain fertility issues, such as polycystic ovary syndrome (PCOS) or low ovarian reserve.

Foliculustan is typically used in combination with other medications, such as human chorionic gonadotropin (hCG) for final maturation of the follicles and luteinizing hormone (LH) for egg retrieval. The dosage and duration of treatment are carefully monitored by healthcare providers to ensure optimal results while minimizing potential side effects.

Common side effects of foliculustan may include ovarian hyperstimulation syndrome (OHSS), which can lead to fluid retention and other complications. Other potential side effects include hot flashes, headaches, and mood changes. It is important for patients to discuss any concerns or symptoms with their healthcare provider.

Foliculustan is available under various brand names, including Gonal-F and Puregon. The use of foliculustan is regulated by medical professionals to ensure its safe and effective application in fertility treatments.